Multiple sclerosis, commonly referred to as MS, is a debilitating disease of the central nervous system. MS affects about 2.3 million people worldwide. Symptoms can range from tingling and numbness to blindness and paralysis. They can vary greatly from one patient to another, and sometimes even in the same… Read More
Stocks to Watch
Warren Buffett doesn't think he can earn 50% annual returns anymore, but he's confident that small investors like you have a chance -- if you know what to do. Read More
When compiling a list of the best coffee stocks to own, Starbucks (NSDQ: SBUX) is usually the first name that comes to mind. And for good reason; Starbucks is the largest publicly traded coffee retailer in the world. With a market value of $80 billion and one of its ubiquitous… Read More
A last-minute deal proposed by its largest shareholder might keep Sears from a death sentence. The iconic retailer's long and slow demise shows the challenges for both bulls and bears in the stock market. Read More
Fundamental rules govern investing. Don't forget these two time-proven principles, which are crucial to any investor's success, regardless of individual profile. Read More
Under Armour is a popular brand among athletes and active people. The company tried to expand too quickly and has paid a price for it. Can it stage a come back? Read More
Uranium is one of the most specialized chemical elements on the planet. Its commercial use is limited to fueling power plants and making weapons. The best uranium stocks to buy now are those that have an inside track on those markets. The nuclear energy sector has undergone considerable change during… Read More
As in the horror movie "Bird Box," investors are blindfolded regarding economic data, due to the government shutdown. How to trade when the future is obscured. Read More
The movement of energy prices can exert a profound effect on your overall portfolio. Here's what we see for the energy sector in 2019. Read More
Gilead has seen its stock price slide in recent years as sales of its hepatitis c drugs are falling sharply. Are better days ahead? Read More